TRIAL DETAIL

Phase II Trial of Locally Advanced/Metastatic Soft Tissue Sarcoma or Imatinib Mesylate Refractory Advanced/Metastatic Malignant GIST

Drug:
Trial Name:
Phase II Trial of Locally Advanced/Metastatic Soft Tissue Sarcoma or Imatinib Mesylate Refractory Advanced/Metastatic Malignant GIST
NCT#:
Conditions:
Sarcoma; Malignant GIST
Status:
Completed
Phase:
2
Start Date 12/01/2006
Age of Trial (yrs) 17.6
Treatment Phase:
Gleevec-resistant
Drug Category:
Chemotherapy
Strategy:
Interfere with production of new DNA
Trial Type:
Specifically GIST plus other cancers
Other Protocol IDs:
T1706
Sponsor:
National Health Research Institutes, Taiwan
Patient Contact:
See site contact info below
Contact email:
Contact Phone:
Randomized:
IV or Oral:
IV Intravenous
Trial Notes:

Trial Links

Trial Results

Drug Information

Gemzar.com
 
Taxotere.com
 

Trial Sites

Name
Address
City
State
Zip
Country
Taichung
Taiwan